ClinicalTrials.gg
RecruitingNCT07823374Updated Sep 16, 2026

Fixation of Free Gingival Graft Using Tissue Tacks vs Criss-cross Sutures

An interventional study of Criss cross sutures and Tissue tacs in Lack of Keratinized Tissue, sponsored by October University for Modern Sciences and Arts. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-09-16.

Sponsored by October University for Modern Sciences and Arts · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year after the study started (first participant enrolled Jan 2025, registered Jan 2026).
  • Started Jan 2025; still recruiting 1 year 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
16
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

Tissue tacks may improve graft stability but their effect on pain is unclear. The study compares tacks and sutures by measuring pain, stability, healing success, and patient comfort.

Read the detailed description

Tissue tacks are a newer method for securing free gingival grafts ,offering potential benefits such as improved graft stability and reduced movement compared to traditional criss- cross sutures. However, the impact of tissue tacks on postoperative pain remains unclear. This study seeks to evaluate whether tissue tacks, while possibly enhancing graft stability and healing, result in higher pain levels compared to sutures, and whether these outcomes affect the overall clinical success and patient comfort during healing.

02

Conditions studied

  • Lack of Keratinized Tissue
03

In context

Lead sponsor

October University for Modern Sciences and Arts is the lead sponsor of 51 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with inadequate keratinized tissue requiring free gingival grafts.
  • Age between 18-40 years.
  • Free from systemic diseases that could affect healing.
  • Good oral hygiene.
  • Motivated patients with a willingness to participate and comply with post-operative instructions.

Exclusion criteria

Exclusion Criteria:

  • Medically compromised patients
  • Subjects who underwent radiotherapy or chemotherapy, pregnant women, smokers.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
16 participants (estimated)

Study arms

  • Other
    criss cross sutures

    Fixation of free gingival graft using tissue tacs

    Procedure: Criss cross sutures

  • Active comparator
    tissue tacs

    Fixation of free gingival graft using tissue tacs

    Procedure: Tissue tacs

Interventions

  • ProcedureCriss cross sutures

    Fixation of free gingival graft using criss cross sutures

  • ProcedureTissue tacs

    Fixation of free gingival graft using tissue tacs

06

What researchers measure

Primary outcomes

  1. Pain score (VAS Score)

    Grade from 1-10

    Time frame: 1,3,5,7 days post surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — All IPD

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2025 (actual). Primary completion is estimated for Sep 2026, 20 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 12, 2026
First posted
Sep 16, 2026
StartActual
Jan 1, 2025
Primary completionEst.
Sep 30, 2026
CompletionEst.
Sep 30, 2026
Last update
Sep 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07823374
Lead sponsor
October University for Modern Sciences and Arts
Responsible party
Sponsor
First posted
Sep 16, 2026
Start date
Jan 1, 2025
Primary completion
Sep 30, 2026 (estimated)
Completion
Sep 30, 2026 (estimated)
Last update
Sep 16, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion